MDBH MDB CAPITAL HOLDINGS LLC

New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market

New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market

Designed for investors, board members, and CEOs, the latest PatentVest Pulse offers a strategic view of who’s winning—and why—in the emerging BCI market

Dallas, TX, April 01, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and strategy firm, has released its latest PatentVest Pulse report on brain-computer interfaces (BCIs). Titled ,” the report reveals how control over intellectual property—not just innovation—is shaping the future of neurotechnology.

Neurological disorders represent one of the fastest-growing and highest-need areas in global healthcare, with millions affected by conditions such as paralysis, epilepsy, stroke, and treatment-resistant depression. As traditional treatments struggle to deliver meaningful outcomes, BCIs are emerging as a next-generation solution—restoring lost function, enabling new capabilities, and shifting neurological care from reactive to proactive.

The U.S. market for BCIs is projected to exceed $400 billion. Approximately $80 billion is concentrated in high-acuity, early-adopting patient populations already aligning with clinical and reimbursement pathways. A further $320 billion in long-term potential lies in broader neurological and psychiatric conditions, where early alignment of intellectual property, clinical validation, and commercialization strategy will be critical to scaling. While the opportunity is vast, long-term value will accrue to the companies that move early to secure technical, clinical, and IP leadership.

This report delivers a first-of-its-kind strategic lens into the BCI market—combining deep company-level benchmarking with a comprehensive IP landscape analysis. It profiles the clinical strategies, platform architectures, and patent portfolios of the most prominent BCI players—including Synchron, Neuralink, Blackrock Neurotech, Precision Neuroscience, INBRAIN Neuroelectronics, Paradromics, Axoft, Motif Neurotech, and Science Corp—while mapping over 2,160 patent families across 664 entities to identify the companies, universities, and innovation clusters shaping the future of neurotechnology.

Key Insights:

  • Strategic Leaders Are Emerging: While Neuralink commands visibility, Synchron is quietly establishing category leadership through a minimally invasive platform, global partnerships, and a highly targeted IP strategy spanning 10 jurisdictions. Other leaders—including INBRAIN, Blackrock, Precision Neuroscience, and Paradromics—are staking out defensible positions through differentiated technologies, clinical focus areas, and early IP consolidation.
  • Corporate IP Consolidation: More than 2,160 unique BCI patent families are now held by companies like NeuroPace, Neurolutions, Cognixion, Neurable, Snap (NextMind), Panasonic, Arctop, and CereGate—highlighting an accelerating arms race for control over system-level intellectual property.
  • Universities Still Control the Foundations: Academic institutions such as Tianjin University, Stanford, and the University of California continue to dominate early-stage innovation, holding foundational patents in neural signal processing, interface architecture, and adaptive systems—establishing the starting line for many of today’s commercial efforts.

“Neuralink may command the headlines, but it's companies like Synchron and INBRAIN that are quietly securing the innovation real estate that will shape the future of neurotechnology,” said Will Rosellini, Chief IP Officer at PatentVest. “That’s exactly why we built the PatentVest Pulse—to give boards and investors visibility into the IP dynamics that actually define market leadership, beyond the noise.”

Access the Full Report

The PatentVest Pulse report is now available. Get the data, insights, and strategic intelligence behind the companies shaping the future of BCI: .

For more information or inquiries, please contact .

About PatentVest

PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is the first integrated IP intelligence, strategy, and law firm to enable visionary companies to develop into technology leaders. By combining our proprietary database with a time proven IP diligence process and expert analysis, we deliver actionable insights on the IP landscape to help our clients make informed decisions and stay ahead of the curve. The trends and competitive insights in this report are powered by PatentVest's proprietary IP intelligence platform. Our reports keep a pulse on the key players, technologies, and opportunities shaping deep technology markets.



EN
01/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MDB CAPITAL HOLDINGS LLC

 PRESS RELEASE

MDB Capital Holdings Provides Second Quarter 2025 Update

MDB Capital Holdings Provides Second Quarter 2025 Update Management to Host Conference Call Today at 4:30 p.m. ET Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended June 30, 2025, and subsequent developments. Second Quarter 2025 and Subsequent Operational Highlights Launched private offering for Paulex Bio, a company developing a transformational oral medication designed to eliminate th...

 PRESS RELEASE

PatentVest and Docana Announce Strategic Partnership to Accelerate IP ...

PatentVest and Docana Announce Strategic Partnership to Accelerate IP Strategy and AI Innovation Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- PatentVest, Inc., a leader in intellectual property strategy and prosecution, announces a strategic partnership with Docana, Inc., an emerging innovator in AI-powered enterprise knowledge extraction. This collaboration represents a shared commitment to advancing scalable innovation through the integration of robust IP frameworks and cutting-edge artificial intelligence. As part of the partnership, PatentVest will provide strategic legal and IP co...

 PRESS RELEASE

PatentVest Releases First-Ever Quantum Computing Rankings

PatentVest Releases First-Ever Quantum Computing Rankings Designed for investors, board members, and CEOs, the latest PatentVest Pulse Report reveals which companies are emerging as true leaders as quantum computing shifts from R&D to commercialization Addison, TX, Aug. 19, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and legal strategy firm, today announced the release of its , the first-ever rankings of leadership in the emerging $850B quantum computing market. Designed for investors, board members, and CEOs, the report profiles 38 companies worldwid...

 PRESS RELEASE

MDB Capital Holdings to Host Second Quarter 2025 Update Conference Cal...

MDB Capital Holdings to Host Second Quarter 2025 Update Conference Call on Wednesday August 27, 2025, at 4:30 p.m. Eastern Time Addison, TX, Aug. 14, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Wednesday August 27, 2025 at 4:30 p.m. Eastern Time to provide a business update for the second quarter 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead ...

 PRESS RELEASE

New PatentVest Pulse Report Maps the Competitive and IP Landscape of t...

New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who’s actually leading and why in one of the most underpenetrated markets in medtech DALLAS, TX , July 10, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP strategy and legal firm, today announced the release of a new report that maps the most important shift in medtech since the rise of the da Vinci system. Built from analysis of more than 18,000 patent families, $4B in M&A activit...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch